- Home
- KRMD vs PROK Comparison
KRMD vs PROK Comparison
Compare KRMD & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRMD
- PROK
- Stock Information
- Founded
- KRMD 1980
- PROK 2015
- Country
- KRMD United States
- PROK United States
- Employees
- KRMD N/A
- PROK N/A
- Industry
- KRMD Medical/Dental Instruments
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- KRMD Health Care
- PROK Health Care
- Exchange
- KRMD Nasdaq
- PROK Nasdaq
- Market Cap
- KRMD 187.5M
- PROK 206.0M
- IPO Year
- KRMD N/A
- PROK N/A
- Fundamental
- Price
- KRMD $3.71
- PROK $1.50
- Analyst Decision
- KRMD Strong Buy
- PROK Buy
- Analyst Count
- KRMD 5
- PROK 5
- Target Price
- KRMD $4.70
- PROK $4.50
- AVG Volume (30 Days)
- KRMD 283.8K
- PROK 344.0K
- Earning Date
- KRMD 03-12-2025
- PROK 03-21-2025
- Dividend Yield
- KRMD N/A
- PROK N/A
- EPS Growth
- KRMD N/A
- PROK N/A
- EPS
- KRMD N/A
- PROK N/A
- Revenue
- KRMD $31,993,796.00
- PROK N/A
- Revenue This Year
- KRMD $20.53
- PROK N/A
- Revenue Next Year
- KRMD $13.94
- PROK N/A
- P/E Ratio
- KRMD N/A
- PROK N/A
- Revenue Growth
- KRMD 11.57
- PROK N/A
- 52 Week Low
- KRMD $2.01
- PROK $1.34
- 52 Week High
- KRMD $5.05
- PROK $4.44
- Technical
- Relative Strength Index (RSI)
- KRMD 34.58
- PROK 41.47
- Support Level
- KRMD $4.55
- PROK $1.50
- Resistance Level
- KRMD $4.83
- PROK $1.67
- Average True Range (ATR)
- KRMD 0.26
- PROK 0.10
- MACD
- KRMD -0.12
- PROK -0.00
- Stochastic Oscillator
- KRMD 2.19
- PROK 10.71
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets, and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of development program for severe diabetic kidney disease.